Ursprung des Netzwerks ersten Grades von Danny Joh
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Danny Joh
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Corporate Officer/Principal | |
Neurocode Labs, Inc. | Chief Tech/Sci/R&D Officer | ||
Royal Institute of Technology | College/University | Doctorate Degree | |
Karolinska Institutet | College/University | Doctorate Degree | |
Eleva GmbH
Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany. | Biotechnology | Chief Executive Officer | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ciliatech Therapeutics AG
Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Ciliatech Therapeutics AG is a Swiss company that focuses on researching, developing, producing, and distributing pharmaceutical and diagnostic products. | Pharmaceuticals: Major | Chief Executive Officer | |
Universität des Saarlandes | College/University | Doctorate Degree | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BC Biomed Consulting GmbH | Chief Executive Officer | ||
Medraxa Therapeutics GmbH | Chief Executive Officer | ||
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Sapreme Technologies BV
Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Biotechnology | Chairman | |
GENSCRIPT BIOTECH CORPORATION | Biotechnology | Corporate Officer/Principal |
Statistik
International
Deutschland | 6 |
Schweden | 4 |
Schweiz | 3 |
Norwegen | 2 |
Kanada | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Commercial Services | 3 |
Finance | 2 |
Operativ
Chief Executive Officer | 4 |
Chairman | 4 |
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Björn Cochlovius | 14 |
Hans Frykman | 4 |
Berkan Unal | 2 |